{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:14:02Z","timestamp":1783527242924,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Racial and Ethnic Health Disparities"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s40615-025-02486-7","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T14:56:28Z","timestamp":1748357788000},"page":"3117-3124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Probability of Stroke in Blacks and Non-Hispanic Whites Treated with ACE-I, ARBs, and Other Antihypertensives"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8299-7536","authenticated-orcid":false,"given":"Anna Katja Maria","family":"Chesterman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Denney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaikh","family":"Afaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa Stradley","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais M.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"key":"2486_CR1","unstructured":"V. Feigin, B. Stark, Owens Johnson C and et al, \"Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019,\" Lancet Neurology, pp. 795\u2013820, 2021."},{"key":"2486_CR2","unstructured":"C. Tsao, A. Aday, Z. Almarzooq and et al, \"Heart Disease and Stroke Statistics-2023 Update: a report from the American Heart Association,\" Circulation, pp. 93\u2013621, 2023."},{"key":"2486_CR3","doi-asserted-by":"crossref","unstructured":"G. Howard, D. Lackland, D. Kleindorfer and et al, \"Racial differences in the impact of elevated systolic blood pressure on stroke risk,\" JAMA Internal Medicine, pp. 46\u201351, 2013.","DOI":"10.1001\/2013.jamainternmed.857"},{"key":"2486_CR4","doi-asserted-by":"crossref","unstructured":"A. Oluwasegun, B. Jaeger, T. Moore and et al, \"Racial differences in blood pressure control following stroke: The REGARDS Study,\" Stroke, pp. 3944\u20133952, 2021.","DOI":"10.1161\/STROKEAHA.120.033108"},{"key":"2486_CR5","doi-asserted-by":"crossref","unstructured":"E. Rapsomaniki, A. Timmis, M. Pujades-Rodriguez and et al, \"Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1\u00b725 million people,\" Lancet, pp. 1899\u2013911, 2014.","DOI":"10.1016\/S0140-6736(14)60685-1"},{"issue":"5","key":"2486_CR6","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41440-024-01622-w","volume":"47","author":"K Kazuomi","year":"2024","unstructured":"Kazuomi K, Ayako O, Satoshi H, Masaki M. The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy. Hypertension research: official journal of the Japanese Society of Hypertension. 2024;47(5):1099\u2013102.","journal-title":"Hypertension research: official journal of the Japanese Society of Hypertension"},{"key":"2486_CR7","doi-asserted-by":"crossref","unstructured":"A. Helmer, N. Slater and S. Smithgall, \"A review of ACE inhibitors and ARBs in Black patients with hypertension,\" Annals of Pharmacotherapy, pp. 1143\u20131151, 2018.","DOI":"10.1177\/1060028018779082"},{"key":"2486_CR8","doi-asserted-by":"crossref","unstructured":"P. Muntner, S. Hardy, L. Fine and et al, \"Trends in blood pressure control among US adults with hypertension, 1999\u20132000 to 2017\u20132018,\" JAMA, pp. 1190\u20131200, 2020.","DOI":"10.1001\/jama.2020.14545"},{"key":"2486_CR9","doi-asserted-by":"crossref","unstructured":"S. Oparil, \"Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): practical implications,\" Hypertension, pp. 1006\u20131009, 2003.","DOI":"10.1161\/01.HYP.0000070905.09395.F6"},{"key":"2486_CR10","doi-asserted-by":"crossref","unstructured":"J. Wright Jr, J. Kay Dunn, B. Davis and et al, \"Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril,\" JAMA, pp. 1595\u20131608, 2005.","DOI":"10.1001\/jama.293.13.1595"},{"key":"2486_CR11","doi-asserted-by":"crossref","unstructured":"A. Al-Makki, D. DiPette, P. Whelton and et al, \"Hypertension pharmacological treatment in adults: A World Health Organization Guideline Executive Summary,\" Hypertension, pp. 293\u2013301, 2022.","DOI":"10.1161\/HYPERTENSIONAHA.121.18192"},{"key":"2486_CR12","doi-asserted-by":"crossref","unstructured":"J.-M. Yamal, S. Oparil, B. Davis, M. Alderman, D. Calhoun, W. Cushman and et al, \"Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT,\" Journal of the American Society of Hypertension, pp. 808\u2013819, 2014.","DOI":"10.1016\/j.jash.2014.08.003"},{"key":"2486_CR13","doi-asserted-by":"crossref","unstructured":"B. Materson, D. Reda, B. Massie and et al, \"Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents,\" New England Journal of Medicine, pp. 914\u2013921, 1993.","DOI":"10.1056\/NEJM199304013281303"},{"key":"2486_CR14","doi-asserted-by":"crossref","unstructured":"J. Clemmer, W. Pruett and S. Lirette, \"Racial and sex differences in the response to first-line antihypertensive therapy,\" Frontiers in Cardiovascular Medicine, 2020.","DOI":"10.3389\/fcvm.2020.608037"},{"key":"2486_CR15","doi-asserted-by":"crossref","unstructured":"M. Moser and J. Lunn, \"Responses to captopril and hydrochlorothiazide in black patients with hypertension,\" Clinical Pharmacology & Therapeutics, pp. 307\u2013312, 1982.","DOI":"10.1038\/clpt.1982.165"},{"key":"2486_CR16","doi-asserted-by":"crossref","unstructured":"T. Brown, J. Gonzalez and C. Monteleone, \"Angiotensin-converting enzyme inhibitor-induced angioedema: a review of the literature,\" The Journal of Clinical Hypertension, pp. 1377\u20131382, 2017.","DOI":"10.1111\/jch.13097"},{"key":"2486_CR17","doi-asserted-by":"crossref","unstructured":"J. Cohn, \"Contemporary treatment of heart failure: is there adequate evidence to support a unique strategy for African-Americans? Pro position,\" Current Hypertension Reports, pp. 307\u2013310, 2002.","DOI":"10.1007\/s11906-996-0009-8"},{"key":"2486_CR18","doi-asserted-by":"crossref","unstructured":"C. Lu, R. Ahmed, A. Lamri and et al, \"Use of race, ethnicity, and ancestry data in health research,\" PLOS Global Publich Health, 2022.","DOI":"10.31219\/osf.io\/z4xty"},{"key":"2486_CR19","doi-asserted-by":"crossref","unstructured":"E. Aradine, K. Ryan, C. Cronin and et al, \"Black-white differences in ischemic stroke risk factor burden in young adults,\" Stroke, pp. 66\u201369, 2022.","DOI":"10.1161\/STROKEAHA.121.034314"},{"key":"2486_CR20","doi-asserted-by":"crossref","unstructured":"M. Suchard, M. Schuemie, H. Krumholtz and et al, \"Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis,\" Lancet, pp. 1816\u20131826, 2019.","DOI":"10.1016\/S0140-6736(19)32317-7"}],"container-title":["Journal of Racial and Ethnic Health Disparities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-025-02486-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40615-025-02486-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-025-02486-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:19:57Z","timestamp":1783523997000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40615-025-02486-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2486"],"URL":"https:\/\/doi.org\/10.1007\/s40615-025-02486-7","relation":{},"ISSN":["2197-3792","2196-8837"],"issn-type":[{"value":"2197-3792","type":"print"},{"value":"2196-8837","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was determined to be exempt or excluded from Institutional Review Board (IRB) oversight in accordance with current regulations and institutional policy. Our internal HCA Healthcare reference number for this determination is 2023\u2013228.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}